Research on treatment for Congo's deadly Ebola

A clinical trial is underway in Congo to test an experimental antiviral pill aimed at preventing Ebola infection among high-risk contacts, including health workers and family members, amid the ongoing outbreak caused by the Bundibugyo virus. Over 250 participants have been enrolled since July in an effort to determine if the drug can stop the disease before symptoms appear, with the outbreak infecting thousands and spreading across multiple provinces. The trial involves monitoring participants for 21 days, with the goal of providing a new method of post-exposure prevention.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل